Loading...
Getinge AB (publ)
GNGBY•PNK
Healthcare
Medical - Devices
$21.01
$0.06(0.28%)
Getinge AB (publ) (GNGBY) Financial Performance & Income Statement Overview
Review Getinge AB (publ)’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
9.21%
↑ 9.21%
Operating Income Growth
-23.61%
↓ 23.61%
Net Income Growth
-32.09%
↓ 32.09%
Operating Cash Flow Growth
54.79%
↑ 54.79%
Operating Margin
7.79%
↑ 7.79%
Gross Margin
46.002%
↑ 46.002%
Net Profit Margin
4.16%
↑ 4.16%
ROE
4.72%
↑ 4.72%
ROIC
5.98%
↑ 5.98%
Getinge AB (publ) (GNGBY) Income Statement & Financial Overview
Review Getinge AB (publ)'s (GNGBY) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $8.32B | $11.07B | $7.87B | $8.30B |
| Cost of Revenue | $4.22B | $6.02B | $4.32B | $4.65B |
| Gross Profit | $4.09B | $5.05B | $3.56B | $3.66B |
| Gross Profit Ratio | $0.49 | $0.46 | $0.45 | $0.44 |
| R&D Expenses | $318.00M | $446.00M | $319.00M | $338.00M |
| SG&A Expenses | $2.77B | $2.96B | $2.46B | $2.65B |
| Operating Expenses | $3.50B | $3.97B | $3.37B | $2.75B |
| Total Costs & Expenses | $7.72B | $9.99B | $7.69B | $7.40B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $152.00M | $130.00M |
| Depreciation & Amortization | $566.00M | $935.00M | $522.00M | $493.00M |
| EBITDA | $1.46B | $2.64B | $861.00M | $1.40B |
| EBITDA Ratio | $0.18 | $0.24 | $0.11 | $0.17 |
| Operating Income | $598.00M | $1.08B | $184.00M | $906.00M |
| Operating Income Ratio | $0.07 | $0.10 | $0.02 | $0.11 |
| Other Income/Expenses (Net) | -$170.00M | -$173.00M | -$152.00M | -$130.00M |
| Income Before Tax | $428.00M | $911.00M | $32.00M | $700.00M |
| Income Before Tax Ratio | $0.05 | $0.08 | $0.004 | $0.08 |
| Income Tax Expense | $124.00M | $243.00M | $23.00M | $187.00M |
| Net Income | $300.00M | $664.00M | $2.00M | $513.00M |
| Net Income Ratio | $0.04 | $0.06 | $0.00 | $0.06 |
| EPS | $1.10 | $2.44 | $0.007 | $1.88 |
| Diluted EPS | $1.10 | $2.44 | $0.007 | $1.88 |
| Weighted Avg Shares Outstanding | $272.37M | $272.37M | $272.37M | $272.37M |
| Weighted Avg Shares Outstanding (Diluted) | $272.37M | $272.37M | $272.37M | $272.37M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan